Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain;Prevalencia de los marcadores de infección de los virus de las hepatitis en pacientes portadores del VIH en el sur de España

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 8, 2012, Pages 452-457

  Cifuentes, Celia ^a   Mira, José A ^a   Vargas, Julio ^a   Neukam, Karin ^a   Escassi, Carmen ^a   García Rey, Silvia ^a   Gilabert, Isabel ^a   González Monclova, Marian ^a   Bernal, Samuel ^a   Pineda, Juan A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Hepatitis A virus (HAV); Hepatitis B virus (HBV); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV)

Indexed keywords

BIOLOGICAL MARKER; VIRUS ANTIBODY; VIRUS RNA;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GENOTYPE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PROSPECTIVE STUDY; SPAIN; TERTIARY HEALTH CARE; VACCINATION;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEXUALITY; SPAIN; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 84866735876     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.12.008     Document Type: Article

References (23)

1. M.J. Alter Epidemiology of viral hepatitis and HIV co-infection J Hepatol 44 2006 S6 S9
2. M.J. Koziel, and M.G. Peter Viral hepatitis in HIV infection N Engl J Med 356 2007 1445 1454
3. J.J. González-García, B. Mahillo, S. Hernández, R. Pacheco, S. Diz, and P. García Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study Enferm Infecc Microbiol Clin 23 2005 340 348
4. B. Ramos, M. Núñez, C. Toro, J. Sheldon, J. García-Samaniego, and P. Ríos Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients J Infect 54 2007 173 179
5. S. Pérez-Cachafeiro, J. Del Amo, J.A. Iribarren, M. Salavert, F. Gutiérrez, and A. Moreno Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006 Clin Infect Dis 48 2009 1467 1470
6. J.A. Pineda, J.A. Mira, I. de los Santos-Gil, B. Valera-Bestard, A. Rivero, and D. Merino Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients J Antimicrob Chemother 60 2007 1347 1354
7. M. Núñez, C. Miralles, M.A. Berdún, E. Losada, K. Aguirrebengoa, and A. Ocampo Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial AIDS Res Hum Retroviruses 23 2007 972 982
8. K. Neukam, J. Macías, J.A. Mira, and J.A. Pineda A review of current anti-HCV treatment regimens and possible future strategies Expert Opin Pharmacother 10 2009 417 433
9. Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el estudio del Hígado (AEEH). Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus. Enferm Infecc Microbiol Clin. 2010;28:1-31.
10. N. Merchante, J.A. Girón-González, M. González- Serrano, J. Torre-Cisneros, J.A. García-García, and A. Arizcorreta Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease AIDS 20 2006 49 57
11. B. Roca, I. Suárez, J. González, M. Garrido, B. De la Fuente, and R. Teira Hepatitis C virus and human immunodeficiency virus coinfection in Spain J Infect 47 2003 117 124
12. J. Andreu, M.A. Abad, A. Sanchez-Quijano, R. Torronteras, F. Luque, and García de las Heras High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group J Intern Med 236 1994 73 77
13. E. Lissen, H.J. Alter, M.A. Abad, Y. Torres, M. Pérez-Romero, and M. Leal Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases Eur J Clin Microbiol Infect Dis 12 1993 827 831
14. M.A. Morales, J.A. Pineda, M. Leal, R. Pino, R. Torronteras, and A. Sánchez-Quijano Prevalence of antibodies against hepatitis C virus in a sample of homosexual males Med Clin (Barc) 100 1993 50 52
15. A. Sánchez-Quijano, C. Rey, I. Aguado, J.A. Pineda, M. Pérez-Romero, and Y. Torres Hepatitis C virus infection in sexually promiscuous groups Eur J Clin Microbiol Infect Dis 9 1990 610 612
16. A. Rauch, M. Rickenbach, R. Weber, B. Hirshel, P. Tarr, and H. Bucher Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV cohort study Clin Infect Dis 41 2005 395 402
17. T.J. Van de Laar, A. van der Bij, M. Prins, S. Bruisten, K. Brinkman, and T. Ruys Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission J Infect Dis 196 2007 230 238
18. T.J. Van de Laar, G.V. Matthews, M. Prins, and M. Danta Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection AIDS 24 2010 1799 1812
19. J. Berenguer, J. Alvarez-Pellicer, P.M. Martín, J. López-Aldeguer, M.A. Von-Wichmann, and C. Quereda Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus Hepatology 50 2009 407 413
20. S.H. Mehta, D.L. Thomas, M.S. Sulkowski, M. Safaein, D. Vlahov, and S.A. Strathdee A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users AIDS 19 Suppl 3 2005 S179 S189
21. A.S. Zinkernagel, V. von Wyl, B. Ledergerber, M. Rickenbach, H. Furrer, and M. Battegay Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study Antivir Ther 11 2006 131 142
22. J. Medrano, S. Resino, E. Vispo, A. Madejón, P. Labarga, and P. Tuma Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients J Viral Hepat 18 2011 325 330
23. L. Salleras, M. Bruguera, J. Vidal, J.L. Taberner, P. Plans, and M.T. Jiménez de Anta A change in the epidemiologic pattern of hepatitis A in Spain Med Clin 99 1992 87 89